RenovoRx (RNXT) Earnings Date & Reports

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RNXT is expected to report earnings to fall 8.38% to -7 cents per share on August 13

Q2'25

Est.

$-0.07

Q1'25

Beat

by $0.01

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.02

Q2'24

Est.

$-0.10

The last earnings report on May 15 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 73.39K shares outstanding, the current market capitalization sits at 44.98M.

View a ticker or compare two or three

Compare

RNXT